Keywords: astrazeneca, cheers, investors, 3rd-qtr, profits, rise, increased
AstraZeneca cheers investors, with 29% 3rd-qtr profits rise and increased target
Article | 10 November 2008
Anglo-Swedish pharmaceutical major AstraZeneca saw its share price jump 5.2% on October 30, after the firm posted third-quarter 2008 results that beat expectations, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
